EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.8100
-0.0300 (-3.57%)
At close: Mar 31, 2026
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 38.13 million as of March 31, 2026. Its market cap has decreased by -46.65% in one year.
Market Cap
38.13M
Enterprise Value
23.57M
Revenue
61.40M
Ranking
n/a
PE Ratio
13.20
Stock Price
0.81
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 38.13M, a decrease of -21.75%. That is a compound annual growth rate of -4.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 38.13M | -42.52% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cynata Therapeutics | 72.42M |
| Immutep | 69.26M |
| Prescient Therapeutics | 54.68M |
| Neurizon Therapeutics | 53.11M |
| Imugene | 48.20M |
| Entropy Neurodynamics | 44.47M |
| Proteomics International Laboratories | 42.95M |
| Algorae Pharmaceuticals | 31.70M |